Table 6.

Financial benefits (in €) due to vaccination of previously vaccinated sows (preVS) with nVac instead of a previously used licensed vaccine (vaccination coverage fixed at 60%).

Proportion of nVac in preVS	Vaccination effectiveness
	+5%	+10%	+15%	+20%	+25%
10%	1′715′580	3′431′160	5′146′740	6′862′320	8′577′900
20%	3′431′160	6′862′320	10′293′480	13′724′640	17′155′800
30%	5′146′740	10′293′480	15′440′220	20′586′960	25′733′700
40%	6′862′320	13′724′640	20′586′960	27′449′280	34′311′600
50%	8′577′900	17′155′800	25′733′700	34′311′600	42′889′500
60%	10′293′480	20′586′960	30′880′440	41′173′920	51′467′400
70%	12′009′060	24′018′120	36′027′180	48′036′240	60′045′300
80%	13′724′640	27′449′280	41′173′920	54′898′560	68′623′200
90%	15′440′220	30′880′440	46′320′660	61′760′880	77′201′100
100%	17′155′800	34′311′600	51′467′400	68′623′200	85′779′000